IBDEI0VM ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15593,1,4,0)
 ;;=4^338.22
 ;;^UTILITY(U,$J,358.3,15593,1,5,0)
 ;;=5^Chronic Post-Thoracotomy Pain
 ;;^UTILITY(U,$J,358.3,15593,2)
 ;;=^334075
 ;;^UTILITY(U,$J,358.3,15594,0)
 ;;=338.28^^89^909^28
 ;;^UTILITY(U,$J,358.3,15594,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15594,1,4,0)
 ;;=4^338.28
 ;;^UTILITY(U,$J,358.3,15594,1,5,0)
 ;;=5^Other Chronic Postop Pain
 ;;^UTILITY(U,$J,358.3,15594,2)
 ;;=^334076
 ;;^UTILITY(U,$J,358.3,15595,0)
 ;;=338.29^^89^909^27
 ;;^UTILITY(U,$J,358.3,15595,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15595,1,4,0)
 ;;=4^338.29
 ;;^UTILITY(U,$J,358.3,15595,1,5,0)
 ;;=5^Other Chronic Pain
 ;;^UTILITY(U,$J,358.3,15595,2)
 ;;=^334077
 ;;^UTILITY(U,$J,358.3,15596,0)
 ;;=338.3^^89^909^8
 ;;^UTILITY(U,$J,358.3,15596,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15596,1,4,0)
 ;;=4^338.3
 ;;^UTILITY(U,$J,358.3,15596,1,5,0)
 ;;=5^Cancer Associated Pain
 ;;^UTILITY(U,$J,358.3,15596,2)
 ;;=^334078
 ;;^UTILITY(U,$J,358.3,15597,0)
 ;;=338.4^^89^909^11
 ;;^UTILITY(U,$J,358.3,15597,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15597,1,4,0)
 ;;=4^338.4
 ;;^UTILITY(U,$J,358.3,15597,1,5,0)
 ;;=5^Chronic Pain Syndrome
 ;;^UTILITY(U,$J,358.3,15597,2)
 ;;=^334079
 ;;^UTILITY(U,$J,358.3,15598,0)
 ;;=780.96^^89^909^17
 ;;^UTILITY(U,$J,358.3,15598,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15598,1,4,0)
 ;;=4^780.96
 ;;^UTILITY(U,$J,358.3,15598,1,5,0)
 ;;=5^Generalized Pain
 ;;^UTILITY(U,$J,358.3,15598,2)
 ;;=^334163
 ;;^UTILITY(U,$J,358.3,15599,0)
 ;;=607.9^^89^909^30
 ;;^UTILITY(U,$J,358.3,15599,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15599,1,4,0)
 ;;=4^607.9
 ;;^UTILITY(U,$J,358.3,15599,1,5,0)
 ;;=5^Penile Pain
 ;;^UTILITY(U,$J,358.3,15599,2)
 ;;=^270442
 ;;^UTILITY(U,$J,358.3,15600,0)
 ;;=608.9^^89^909^32
 ;;^UTILITY(U,$J,358.3,15600,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15600,1,4,0)
 ;;=4^608.9
 ;;^UTILITY(U,$J,358.3,15600,1,5,0)
 ;;=5^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,15600,2)
 ;;=^123856
 ;;^UTILITY(U,$J,358.3,15601,0)
 ;;=V68.1^^89^910^4
 ;;^UTILITY(U,$J,358.3,15601,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15601,1,4,0)
 ;;=4^V68.1
 ;;^UTILITY(U,$J,358.3,15601,1,5,0)
 ;;=5^Rx Refill (Also mark Condition)
 ;;^UTILITY(U,$J,358.3,15601,2)
 ;;=RX Refill (also mark Condition)^295585
 ;;^UTILITY(U,$J,358.3,15602,0)
 ;;=V68.81^^89^910^6
 ;;^UTILITY(U,$J,358.3,15602,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15602,1,4,0)
 ;;=4^V68.81
 ;;^UTILITY(U,$J,358.3,15602,1,5,0)
 ;;=5^Transfer of Care (Also Mark Dx)
 ;;^UTILITY(U,$J,358.3,15602,2)
 ;;=Transfer of Care ^295587
 ;;^UTILITY(U,$J,358.3,15603,0)
 ;;=V58.83^^89^910^5
 ;;^UTILITY(U,$J,358.3,15603,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15603,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,15603,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,15603,2)
 ;;=Encounter for Therapeutic Drug Monitoring^322076
 ;;^UTILITY(U,$J,358.3,15604,0)
 ;;=V65.19^^89^910^3
 ;;^UTILITY(U,$J,358.3,15604,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15604,1,4,0)
 ;;=4^V65.19
 ;;^UTILITY(U,$J,358.3,15604,1,5,0)
 ;;=5^Person Consulting on Behalf of Pt
 ;;^UTILITY(U,$J,358.3,15604,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,15605,0)
 ;;=V60.89^^89^910^1
 ;;^UTILITY(U,$J,358.3,15605,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15605,1,4,0)
 ;;=4^V60.89
 ;;^UTILITY(U,$J,358.3,15605,1,5,0)
 ;;=5^Housing/Economic Circumstances
 ;;^UTILITY(U,$J,358.3,15605,2)
 ;;=^295545
 ;;^UTILITY(U,$J,358.3,15606,0)
 ;;=V68.09^^89^910^2
 ;;^UTILITY(U,$J,358.3,15606,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15606,1,4,0)
 ;;=4^V68.09
